Genomic medicine is rapidly changing the healthcare paradigm for multiple conditions, including cancer and rare diseases. With governments around the world increasingly investing in genomics research and implementation into clinical practice, and with the health economics evidence base on genomic medicine expanding, it is important to reflect on the role of health economics to change …

Prioritising genomic medicine: reflections on the role of health economics for changing policy and clinical practice Read More »

Presenter: Ann Livingstone, University of Sydney Ann was recently awarded her PhD. She has a keen interest in patient preferences in trial-based and modelled economic evaluation. In addition, she works as an evaluator for the Australian Medical Services Advisory Committee, reviewing and critiquing evidence to inform government policy decision-making regarding health technologies. Adjuvant immunotherapy has …

Preferences for Adjuvant Immunotherapy in Resected Stage III Melanoma Read More »

Presenters: Kara Hanson, Tim Powell-Jackson, Triin Habicht, Shankar Prinja In this webinar, we are going to present the findings from our Lancet Global Health Commission on Financing PHC report on two key issues: Resource Allocation and Provider Payment. We will also present two country case studies from India and Estonia to illustrate the problems and …

Financing PHC in LMICs: Putting People at the Centre Read More »

Presenters: Veloshnee Govender, Rajalakshmi RamPrakash, Michelle Remme,  Lavanya Vijayasingham   In this webinar we argue that gender equity has been relatively neglected in the field of health economics. This neglect has been to the detriment of building theory, research and health policy and programme implementation. We will illustrate our argument through specific application of gender …

Where is Gender in Health Economics? Read More »